Donaldson delivered a strong Q1 FY26 performance with record revenue and earnings, driven by growth in replacement parts, new equipment sales, and cost optimization efforts.
Revenue reached $935.4M, up 3.9% from the prior year.
Net income rose to $113.9M, reflecting strong margin leverage.
Adjusted EPS increased to $0.94 despite soft On-Road and Defense sales.
Life Sciences segment led growth with a 13.1% revenue increase.
Donaldson raised its FY26 adjusted EPS and operating margin guidance, anticipating continued growth despite soft areas in Defense and On-Road markets.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance